These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37533083)

  • 1. Dihydromyricetin ameliorated nonalcoholic steatohepatitis in mice by regulating the composition of serous lipids, bile acids and ileal microflora.
    Miao X; Luo P; Liu J; Wang J; Chen Y
    Lipids Health Dis; 2023 Aug; 22(1):112. PubMed ID: 37533083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of silibinin on serum lipids, bile acids, and gut microbiota in methionine-choline-deficient diet-induced mice.
    Wang W; Zhai T; Luo P; Miao X; Wang J; Chen Y
    Front Nutr; 2023; 10():1257158. PubMed ID: 37867498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soyasaponin A
    Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L
    Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Honokiol affects the composition of gut microbiota and the metabolism of lipid and bile acid in methionine-choline deficiency diet-induced NASH mice.
    Zhai T; Wang J; Chen Y
    Sci Rep; 2023 Sep; 13(1):15203. PubMed ID: 37709801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota Plays Essential Roles in Soyasaponin's Preventive Bioactivities against Steatohepatitis in the Methionine and Choline Deficient (MCD) Diet-Induced Non-Alcoholic Steatohepatitis (NASH) Mice.
    Su C; Wang J; Luo H; Chen J; Lin F; Mo J; Xiong F; Zha L
    Mol Nutr Food Res; 2024 Feb; 68(4):e2300561. PubMed ID: 38234006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
    Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ
    World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.
    Hernandez GV; Smith VA; Melnyk M; Burd MA; Sprayberry KA; Edwards MS; Peterson DG; Bennet DC; Fanter RK; Columbus DA; Steibel JP; Glanz H; Immoos C; Rice MS; Santiago-Rodriguez TM; Blank J; VanderKelen JJ; Kitts CL; Piccolo BD; La Frano MR; Burrin DG; Maj M; Manjarin R
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G582-G609. PubMed ID: 32003601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent Fasting Alleviates Non-Alcoholic Steatohepatitis by Regulating Bile Acid Metabolism and Promoting Fecal Bile Acid Excretion in High-Fat and High-Cholesterol Diet Fed Mice.
    Lin X; Zhu X; Xin Y; Zhang P; Xiao Y; He T; Guo H
    Mol Nutr Food Res; 2023 Jul; 67(14):e2200595. PubMed ID: 37148502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in mice.
    Yamauchi R; Takedatsu H; Yokoyama K; Yamauchi E; Kawashima M; Nagata T; Uchida Y; Kitaguchi T; Higashi T; Fukuda H; Tsuchiya N; Takata K; Tanaka T; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
    Hepatol Int; 2021 Apr; 15(2):392-404. PubMed ID: 33398776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new mechanism of thyroid hormone receptor β agonists ameliorating nonalcoholic steatohepatitis by inhibiting intestinal lipid absorption via remodeling bile acid profiles.
    Sun K; Zhu NL; Huang SL; Qu H; Gu YP; Qin L; Liu J; Leng Y
    Acta Pharmacol Sin; 2024 Oct; 45(10):2134-2148. PubMed ID: 38789494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice.
    Li Q; Li M; Li F; Zhou W; Dang Y; Zhang L; Ji G
    J Ethnopharmacol; 2020 Aug; 258():112896. PubMed ID: 32325178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.
    Rao A; Kosters A; Mells JE; Zhang W; Setchell KD; Amanso AM; Wynn GM; Xu T; Keller BT; Yin H; Banton S; Jones DP; Wu H; Dawson PA; Karpen SJ
    Sci Transl Med; 2016 Sep; 8(357):357ra122. PubMed ID: 27655848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated serum metabolomics, 16S rRNA sequencing and bile acid profiling to reveal the potential mechanism of gentiopicroside against nonalcoholic steatohepatitis in lean mice.
    Li Z; Zhu X; Li C; Tang R; Zou Y; Liu S
    J Ethnopharmacol; 2024 Nov; 334():118526. PubMed ID: 38972531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models.
    Ishioka M; Miura K; Minami S; Shimura Y; Ohnishi H
    Dig Dis Sci; 2017 Feb; 62(2):396-406. PubMed ID: 27913996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure total flavonoids from citrus attenuate non-alcoholic steatohepatitis via regulating the gut microbiota and bile acid metabolism in mice.
    He B; Jiang J; Shi Z; Wu L; Yan J; Chen Z; Luo M; Cui D; Xu S; Yan M; Zhang S; Chen Z
    Biomed Pharmacother; 2021 Mar; 135():111183. PubMed ID: 33401222
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Liu L; Deng L; Wei W; Li C; Lu Y; Bai J; Li L; Zhang H; Jin N; Li C; Zhao C
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary cholesterol drives the development of nonalcoholic steatohepatitis by altering gut microbiota mediated bile acid metabolism in high-fat diet fed mice.
    Gao X; Lin X; Xin Y; Zhu X; Li X; Chen M; Huang Z; Guo H
    J Nutr Biochem; 2023 Jul; 117():109347. PubMed ID: 37031879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of Tibetan medicine Ershiwuwei Songshi Pills in regulating intestinal flora and improving non-alcoholic steatohepatitis].
    Jian CF; Zhang BY; Wang CP; Sha YR; Li AR; Gong PY; Gu J; Tan R
    Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(8):2038-2048. PubMed ID: 35531719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary bile acids supplementation improves the growth performance and alleviates fatty liver in broilers fed a high-fat diet via improving the gut microbiota.
    Hu D; Hou M; Song P; Chen Q; Feng Y; Wu X; Ni Y
    Poult Sci; 2024 Feb; 103(2):103270. PubMed ID: 38056054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of FoxO1 ameliorates hepatic steatosis and hepatitis in nonalcoholic steatohepatitis mice through regulation of gut microbiota.
    Shou DW; Quan Y; Cheng JM; Yang SQ; Chen JW; Li YQ; Huang C; Chen HT; Zhou YJ
    J Dig Dis; 2024 Jul; 25(7):453-462. PubMed ID: 39211938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.